Impact of IFNL4-ΔG genotype on sustained virologic response in hepatitis C genotype 1 patients treated with direct-acting antivirals

被引：5
|
作者：
Backus, Lisa I. [1 ]
Shahoumian, Troy A. [1 ]
Belperio, Pamela S. [1 ]
Winters, Mark [2 ]
Prokunina-Olsson, Ludmila [3 ]
O'Brien, Thomas R. [3 ]
Holodniy, Mark [2 ,4 ]
机构：
[1] Populat Hlth Serv, Dept Vet Affairs, Palo Alto, CA 94304 USA
[2] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
[3] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[4] Off Publ Hlth Surveillance & Res, Dept Vet Affairs, Palo Alto, CA 94304 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2018年 / 92卷 / 01期
基金：
美国国家卫生研究院;
关键词：
IFNL4; SVR; hepatitis C virus; DAA therapy; Veterans; HCV CLEARANCE; VIRUS; IFNL4; ASSOCIATION; INFECTION; RIBAVIRIN; VARIANTS; THERAPY; IL28B;
D O I：
10.1016/j.diagmicrobio.2018.04.004
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
In direct acting antiviral (DAA)-treated HCV genotype 1, the sustained virologic response rate with the Delta G/Delta G genotype of IFNL4 rs368234815 (86.8%) was significantly lower than with Delta G/TT (95.9%, P = 0.03) or TT/IT (98.6%, P = 0.01). The SVR odds ratio for Delta G/Delta G compared to TT/TT was 0.10 (P = 0.03). IFNL4 genotype might predict DAA-response. Published by Elsevier Inc.
引用
收藏
页码：34 / 36
页数：3
相关论文
共 50 条
  • [41] Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting Antivirals
    Mbisa, Jean L.
    Lapp, Zena
    Bibby, David F.
    Phillips, Laura T.
    Manso, Carmen F.
    Packer, Simon
    Simmons, Ruth
    Harris, Kathryn
    Mohan, Jaiganesh
    Chinnappan, Lalitha
    Leitner, Thomas
    Bradshaw, Daniel
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [42] Therapy With Direct-Acting Antivirals for Genotype 3 Patients: Interferon's Last Gasp?
    Esteban, Rafael
    Buti, Maria
    GASTROENTEROLOGY, 2015, 149 (06) : 1326 - 1330
  • [43] Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials
    Struble, Kimberly
    Chan-Tack, Kirk
    Qi, Karen
    Valappil, Thamban
    Connelly, Sarah
    Mishra, Poonam
    Price, Dionne
    Murray, Jeffrey
    Birnkrant, Debra
    JOURNAL OF VIRUS ERADICATION, 2019, 5 (03) : 138 - 144
  • [44] Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis C in the era of new oral direct-acting antivirals: A concise review
    Burgess, Sarah V.
    Hussaini, Trana
    Yoshida, Eric M.
    ANNALS OF HEPATOLOGY, 2016, 15 (02) : 154 - 159
  • [45] Hepatitis B reactivation in a patient with chronic hepatitis C treated with direct-acting antivirals
    Dolores Anton, M.
    Polanco, Ana
    Ferrando, Inmaculada
    Latorre, Patricia
    Pascual, Andrea
    Moreno Osset, Eduardo
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (05): : 317 - 319
  • [46] Pegylated interferon based therapy with second-wave direct-acting antivirals in genotype 1 chronic hepatitis C
    Welch, Nicole M.
    Jensen, Donald M.
    LIVER INTERNATIONAL, 2015, 35 : 11 - 17
  • [47] Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam
    Ong The Due
    Thakkinstian, Ammarin
    Thavorncharoensap, Montarat
    Sobhonslidsuk, Abhasnee
    Wu, Olivia
    Nguyen Khanh Phuong
    Chaikledkaew, Usa
    VALUE IN HEALTH, 2020, 23 (09) : 1180 - 1190
  • [48] Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals
    Barbieri, Diego
    Garcia-Prieto, Ana
    Torres, Esther
    Verde, Eduardo
    Goicoechea, Marian
    Luno, Jose
    CLINICAL KIDNEY JOURNAL, 2019, 12 (03) : 362 - 364
  • [49] Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients
    Abu-Mouch, Saif
    Fireman, Zvi
    Jarchovsky, Jacob
    Zeina, Abdel-Rauf
    Assy, Nimer
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (47) : 5184 - 5190
  • [50] Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct Acting Antivirals for Hepatitis C
    Pan, Jason J.
    Bao, Fei
    Du, Emma
    Skillin, Chase
    Frenette, Catherine T.
    Waalen, Jill
    Alaparthi, Lakshmi
    Goodman, Zachary D.
    Pockros, Pauli J.
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (11) : 1320 - 1330
12345